Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be ...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -A boardroom shake-up at Novo Nordisk has handed ...

The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's ...

Novo Nordisk will replace chair Helge Lund and six independent directors next month in a major boardroom shakeup following a ...

Novo Nordisk is undergoing significant leadership changes, including the replacement of its chair and six independent ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Sure, Eli Lilly’s Tirzepatide-based drugs have caught up significantly to Novo Nordisk’s semaglutide-based ones. As a result, ...

It was a deal with the Danish drugmaker that markets Ozempic and Wegovy that moved Omeros' stock price. Novo Nordisk ( NVO ...

Novo, which installed a new CEO in August to launch a turnaround plan, said chair Helge Lund and the other independent ...

Karen Finerman, CEO & Co-founder, Metropolitan Capital Advisors, said in a recent program on CNBC that she likes NVO amid the ...

Novo Nordisk (NVO) stock is in focus as the FDA OKs a label revison for the company's GLP-1 pill Rybelsus to cut ...

Omeros OMER stock surged 149% after announcing a $2.1 billion licensing deal with Novo Nordisk for its experimental drug ...